• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于靶向代谢组学的上皮性卵巢癌血清代谢物特征

Serum metabolite signatures of epithelial ovarian cancer based on targeted metabolomics.

作者信息

Wang Xinyang, Zhao Xinshu, Zhao Jinhui, Yang Tongshu, Zhang Fengmin, Liu Liyan

机构信息

Department of Microbiology, Harbin Medical University, Harbin, PR China; Wu Lien-Teh Institute, Harbin Medical University, Harbin, PR China.

The Affiliated Tumor Hospital of Harbin Medical University, Harbin, PR China.

出版信息

Clin Chim Acta. 2021 Jul;518:59-69. doi: 10.1016/j.cca.2021.03.012. Epub 2021 Mar 18.

DOI:10.1016/j.cca.2021.03.012
PMID:33746017
Abstract

BACKGROUND

Epithelial ovarian cancer (EOC) is a common gynecological cancer with high mortality rates. The main objective of this study was to investigate the serum amino acid and organic acid profiles to distinguish key metabolites for screening EOC patients.

METHODS

In total, 39 patients with EOC and 31 healthy controls were selected as the training set. Serum amino acid and organic acid profiles were determined using the targeted metabolomics approach. Metabolite profiles were processed via multivariate analysis to identify potential metabolites and construct a metabolic network. Finally, a test dataset derived from 29 patients and 28 healthy controls was constructed to validate the potential metabolites.

RESULTS

Distinct amino acid and organic acid profiles were obtained between EOC and healthy control groups. Methionine, glutamine, asparagine, glutamic acid and glycolic acid were identified as potential metabolites to distinguish EOC from control samples. The areas under the curve for methionine, glutamine, asparagine, glutamic acid and glycolic acid were 0.775, 0 778, 0.955, 0.874 and 0.897, respectively, in the validation study. Metabolic network analysis of the training set indicated key roles of alanine, aspartate and glutamate metabolism as well as D-glutamine and D-glutamate metabolism in the pathogenesis of EOC.

CONCLUSIONS

Amino acid and organic acid profiles may serve as potential screening tools for EOC. Data from this study provide useful information to bridge gaps in the understanding of the amino acid and organic acid alterations associated with epithelial ovarian cancer.

摘要

背景

上皮性卵巢癌(EOC)是一种常见的妇科癌症,死亡率很高。本研究的主要目的是调查血清氨基酸和有机酸谱,以鉴别用于筛查EOC患者的关键代谢物。

方法

总共选取39例EOC患者和31例健康对照作为训练集。采用靶向代谢组学方法测定血清氨基酸和有机酸谱。通过多变量分析处理代谢物谱,以识别潜在的代谢物并构建代谢网络。最后,构建一个来自29例患者和28例健康对照的测试数据集,以验证潜在的代谢物。

结果

EOC组和健康对照组之间获得了不同的氨基酸和有机酸谱。蛋氨酸、谷氨酰胺、天冬酰胺、谷氨酸和乙醇酸被鉴定为区分EOC和对照样本的潜在代谢物。在验证研究中,蛋氨酸、谷氨酰胺、天冬酰胺、谷氨酸和乙醇酸的曲线下面积分别为0.775、0.778、0.955、0.874和0.897。训练集的代谢网络分析表明丙氨酸、天冬氨酸和谷氨酸代谢以及D-谷氨酰胺和D-谷氨酸代谢在EOC发病机制中起关键作用。

结论

氨基酸和有机酸谱可能作为EOC的潜在筛查工具。本研究的数据为填补对与上皮性卵巢癌相关的氨基酸和有机酸改变的理解空白提供了有用信息。

相似文献

1
Serum metabolite signatures of epithelial ovarian cancer based on targeted metabolomics.基于靶向代谢组学的上皮性卵巢癌血清代谢物特征
Clin Chim Acta. 2021 Jul;518:59-69. doi: 10.1016/j.cca.2021.03.012. Epub 2021 Mar 18.
2
Saturated fatty acids as possible important metabolites for epithelial ovarian cancer based on the free and esterified fatty acid profiles determined by GC-MS analysis.基于气相色谱-质谱联用(GC-MS)分析确定的游离脂肪酸和酯化脂肪酸谱,饱和脂肪酸可能是上皮性卵巢癌的重要代谢产物。
Cancer Biomark. 2016 Sep 26;17(3):259-269. doi: 10.3233/CBM-160638.
3
Large-scale profiling of metabolic dysregulation in ovarian cancer.卵巢癌代谢失调的大规模分析
Int J Cancer. 2015 Feb 1;136(3):516-26. doi: 10.1002/ijc.29010. Epub 2014 Jun 17.
4
[Discrimination and clinical value of plasma metabolomic profiles in multidrug resistant epithelial ovarian cancer].[多药耐药上皮性卵巢癌血浆代谢组学图谱的鉴别及临床价值]
Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):896-902. doi: 10.3760/cma.j.issn.0253-3766.2017.12.004.
5
Identification of metabolic biomarkers for diagnosis of epithelial ovarian cancer using internal extraction electrospray ionization mass spectrometry (iEESI-MS).采用内提取电喷雾电离质谱法(iEESI-MS)鉴定上皮性卵巢癌的代谢生物标志物用于诊断。
Cancer Biomark. 2023;37(2):67-84. doi: 10.3233/CBM-220250.
6
Serum 27-nor-5β-cholestane-3,7,12,24,25 pentol glucuronide discovered by metabolomics as potential diagnostic biomarker for epithelium ovarian cancer.代谢组学发现血清 27-去甲-5β-胆甾烷-3,7,12,24,25-五醇葡萄糖醛酸苷可作为上皮性卵巢癌潜在的诊断生物标志物。
J Proteome Res. 2011 May 6;10(5):2625-32. doi: 10.1021/pr200173q. Epub 2011 Apr 19.
7
Taurine, glutamic acid and ethylmalonic acid as important metabolites for detecting human breast cancer based on the targeted metabolomics.基于靶向代谢组学的牛磺酸、谷氨酸和乙基丙二酸在检测人乳腺癌中的重要代谢物
Cancer Biomark. 2018;23(2):255-268. doi: 10.3233/CBM-181500.
8
Predicting ovarian cancer recurrence by plasma metabolic profiles before and after surgery.术前和术后血浆代谢谱预测卵巢癌复发。
Metabolomics. 2018 Apr 26;14(5):65. doi: 10.1007/s11306-018-1354-8.
9
Metabolic phenotyping for monitoring ovarian cancer patients.用于监测卵巢癌患者的代谢表型分析。
Sci Rep. 2016 Mar 21;6:23334. doi: 10.1038/srep23334.
10
Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.基于 UPLC/QTOF/MS 平台的上皮性卵巢癌诊断代谢生物标志物的鉴定。
Acta Oncol. 2012 Apr;51(4):473-9. doi: 10.3109/0284186X.2011.648338. Epub 2012 Jan 27.

引用本文的文献

1
The tumor-promoting role of methionyl-tRNA synthetase 1 in ovarian cancer and its potential mechanisms.甲硫氨酰 - tRNA合成酶1在卵巢癌中的促肿瘤作用及其潜在机制。
Med Oncol. 2025 Apr 29;42(6):187. doi: 10.1007/s12032-025-02741-1.
2
Serum metabolic fingerprints encode functional biomarkers for ovarian cancer diagnosis: a large-scale cohort study.血清代谢指纹图谱编码用于卵巢癌诊断的功能性生物标志物:一项大规模队列研究。
EBioMedicine. 2025 May;115:105706. doi: 10.1016/j.ebiom.2025.105706. Epub 2025 Apr 23.
3
WTAP contributes to platinum resistance in high-grade serous ovarian cancer by up-regulating malic acid: insights from liquid chromatography and mass spectrometry analysis.
WTAP通过上调苹果酸促进高级别浆液性卵巢癌的铂耐药性:来自液相色谱和质谱分析的见解
Cancer Metab. 2025 Mar 17;13(1):14. doi: 10.1186/s40170-025-00383-5.
4
Metabolomics for Clinical Biomarker Discovery and Therapeutic Target Identification.代谢组学在临床生物标志物发现和治疗靶点鉴定中的应用。
Molecules. 2024 May 8;29(10):2198. doi: 10.3390/molecules29102198.
5
A review on trends in development and translation of omics signatures in cancer.癌症中组学特征的发展与转化趋势综述。
Comput Struct Biotechnol J. 2024 Feb 3;23:954-971. doi: 10.1016/j.csbj.2024.01.024. eCollection 2024 Dec.
6
Metabolomic biomarkers in liquid biopsy: accurate cancer diagnosis and prognosis monitoring.液体活检中的代谢组学生物标志物:准确的癌症诊断和预后监测。
Front Oncol. 2024 Feb 7;14:1331215. doi: 10.3389/fonc.2024.1331215. eCollection 2024.
7
Loss of mitochondrial pyruvate carrier 1 supports proline-dependent proliferation and collagen biosynthesis in ovarian cancer.线粒体丙酮酸载体 1 的缺失支持卵巢癌细胞中脯氨酸依赖的增殖和胶原生物合成。
Mol Metab. 2024 Mar;81:101900. doi: 10.1016/j.molmet.2024.101900. Epub 2024 Feb 13.
8
Exploring the causal role of multiple metabolites on ovarian cancer: a two sample Mendelian randomization study.探讨多种代谢物对卵巢癌因果关系的作用:两样本 Mendelian 随机研究。
J Ovarian Res. 2024 Jan 23;17(1):22. doi: 10.1186/s13048-023-01340-w.
9
GC-MS-based untargeted metabolic profiling of malignant mesothelioma plasma.基于 GC-MS 的恶性间皮瘤血浆非靶向代谢组学分析。
PeerJ. 2023 May 18;11:e15302. doi: 10.7717/peerj.15302. eCollection 2023.
10
Machine Learning Reveals Lipidome Remodeling Dynamics in a Mouse Model of Ovarian Cancer.机器学习揭示了卵巢癌小鼠模型中的脂质组重塑动态。
J Proteome Res. 2023 Jun 2;22(6):2092-2108. doi: 10.1021/acs.jproteome.3c00226. Epub 2023 May 23.